Pilot Study of Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia with Deep Molecular Response (EDI-PIO) - Evaluation of Pioglitazone in Treatment-Free Remission

被引：0
|
作者：
Pagnano, Katia B.
Miranda, Eliana C.
Delamain, Marcia Torresan
Duarte, Gislaine Oliveira
Virgilio, Bruna
Vianna, Jessica
De Paula, Erich Vinicius
De Souza, Carmino Antonio
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1595
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia
    Fujioka, Yuki
    Sugiyama, Daisuke
    Matsumura, Itaru
    Minami, Yosuke
    Miura, Masatomo
    Atsuta, Yoshiko
    Ohtake, Shigeki
    Kiyoi, Hitoshi
    Miyazaki, Yasushi
    Nishikawa, Hiroyoshi
    Takahashi, Naoto
    CANCERS, 2021, 13 (23)
  • [42] Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients
    Giovanni Caocci
    Marianna Greco
    Giuseppe Delogu
    Christian Secchi
    Bruno Martino
    Claudia Labate
    Elisabetta Abruzzese
    Malgorzata Monika Trawinska
    Sara Galimberti
    Federica Orru
    Claudio Fozza
    Carlo Gambacorti Passerini
    Francesco Galimi
    Giorgio La Nasa
    Journal of Hematology & Oncology, 9
  • [43] Discontinuation of Imatinib Therapy After Achieving a Molecular Response in Chronic Myeloid Leukemia Patients
    Mahon, Francois-Xavier
    Rea, Delphine
    Guilhot, Francois
    Huguet, Francoise
    Nicolini, Franck Emmanuel
    Legros, Laurence
    Charbonnier, Aude
    Guerci, Agnes
    Varet, Bruno R.
    Etienne, Gabriel
    Aton, Emilie
    Reiffers, Josy
    Rousselot, Philippe
    BLOOD, 2009, 114 (22) : 353 - 353
  • [44] Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients
    Caocci, Giovanni
    Greco, Marianna
    Delogu, Giuseppe
    Secchi, Christian
    Martino, Bruno
    Labate, Claudia
    Abruzzese, Elisabetta
    Trawinska, Malgorzata Monika
    Galimberti, Sara
    Orru, Federica
    Fozza, Claudio
    Passerini, Carlo Gambacorti
    Galimi, Francesco
    La Nasa, Giorgio
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [45] Treatment-Free Remission (TFR) Among Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Not Initially Eligible for Treatment Discontinuation Due to Unstable Deep Molecular Response (DMR): Enestfreedom and Enestop
    Hughes, Timothy P.
    Hochhaus, Andreas
    Kim, Dong-Wook
    Mahon, Francois-Xavier
    Giles, Francis J.
    Radich, Jerald P.
    Ross, David M.
    Gopalakrishna, Prashanth
    Deng, Weiping
    Fellague-Chebra, Rafik
    Acharya, Sandip
    Saglio, Giuseppe
    BLOOD, 2017, 130
  • [46] The EUROSKI biomarker study: analyzing the mechanisms of treatment-free remission in chronic myeloid leukemia
    Rinaldetti, S.
    Sticht, C.
    Pfirrmann, M.
    Nowak, D.
    Fabarius, A.
    Seifarth, W.
    Spiess, B.
    Felde, E.
    Tarnopolskaja, I.
    Hoelting, C.
    Nowak, V.
    Panayiotidis, P.
    Pagoni, M.
    Dimou, M.
    Dengler, J.
    Waller, C. F.
    Brmmendorf, T. H.
    Burchert, A.
    Freunek, G.
    Bueschel, G.
    Goebeler, M. E.
    Klausmann, M.
    Herbst, R.
    Hanzel, S.
    Schafhausen, P.
    Hofmann, W. -K.
    Mahon, F. -X.
    Saussele, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 120 - +
  • [47] Evaluation of Molecular Response to Imatinib Mesylate Treatment in Iranian Patients With Chronic Myeloid Leukemia
    Nekoohesh, Ladan
    Rostami, Shahrbano
    Nikbakht, Mohsen
    Mohammadi, Saeed
    Babakhani, Davood
    Alimoghaddam, Kamran
    Ghahremani, Mohammad H.
    Chahardouli, Bahram
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (01): : E1 - E10
  • [48] Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: Importance of achieving treatment-free remission
    Erba, Harry P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (03) : 242 - 249
  • [49] HLA Polymorphisms Are Associated with Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
    Ureshino, Hiroshi
    Shindo, Takero
    Tanaka, Hidenori
    Saji, Hiroh
    Kimura, Shinya
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (01) : 142 - 149
  • [50] The EUROSKI biomarker study: Analyzing the mechanisms of treatment-free remission in chronic myeloid leukemia
    Sebastien, R.
    Sticht, C.
    Pfirrmann, M.
    Nowak, D.
    Fabarius, A.
    Seifarth, W.
    Spiess, B.
    Panayiotidis, P.
    Pagoni, M.
    Dimou, M.
    Dengler, J.
    Waller, C. F.
    Bruemmendorf, T. H.
    Burchert, A.
    Freunek, G.
    Hofmann, W-K.
    Mahon, F-X.
    Saussele, S.
    ANNALS OF ONCOLOGY, 2017, 28
12345